Nov 20, 2025, 13:19
Combining HIFU and Pharmacotherapy Shows Promise for Adenomyosis-Related Infertility – EJOG
European Journal Obstetrics and Gynecology (EJOG) shared a post on LinkedIn:
“Individualized strategies and future perspectives of high-intensity focused ultrasound combined with pharmacological treatment for adenomyosis-associated infertility: A narrative review
Highlights
- HIFU and medication together may improve pregnancy outcomes in adenomyosis.
- Combining therapies can better reduce pain and preserve the uterus.
- Tailored treatment plans support both fertility and symptom relief.
- Review identifies key challenges in current fertility-focused strategies.
- Future research must define safe, effective protocols for childbearing women.”
Title: Individualized strategies and future perspectives of high-intensity focused ultrasound combined with pharmacological treatment for adenomyosis-associated infertility: A narrative review
Authors: Yong Huang, Lu Yao, Bei Zhuo
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 28, 2026, 16:59Unlocking the Potential of Menstrual Blood in Health Testing – Global Women’s Health Innovation Conclave
-
Jan 28, 2026, 16:57New Insights on Oocyte Yield in Endometriosis and PCOM – RBMO
-
Jan 28, 2026, 16:51Transform Your Expertise with ESHRE eCampus Learning – ESHRE
-
Jan 28, 2026, 16:46Accelerate Your Growth at the AP3G National Meeting – ASRM
-
Jan 28, 2026, 16:43Debojit Saha: Unraveling Chromosomal Errors in Aging Human Eggs
-
Jan 28, 2026, 16:38Silvia Vannuccini: RBMO Highlights Key Insights on Adenomyosis Awareness
-
Jan 28, 2026, 16:32Maximilian Attwood: Challenging Medical Misogyny in Endometriosis Research
-
Jan 28, 2026, 16:29Ioakeim Sapantzoglou: New Perspectives on Fetal Growth Restriction and Genetic Testing
-
Jan 28, 2026, 16:26Enhancing Pre-Eclampsia Prediction with Doppler Indices – ISUOG